Dr. Chao Wang is a surgeon specializing in hepato-pancreato-biliary surgery and liver transplantation at The Affiliated Hangzhou First People’s Hospital of Zhejiang University, where he is actively involved in advanced clinical care, research, and surgical innovation. He received comprehensive medical training in general surgery and has developed strong expertise in liver transplantation, hepatobiliary malignancies, and pancreatic diseases. His clinical practice focuses on complex surgical management and post-transplant outcomes, integrating precision medicine into patient care. Dr. Wang’s research centers on the molecular and genetic mechanisms influencing liver transplantation outcomes, hepatocellular carcinoma recurrence, graft fibrosis, and metabolic complications following transplantation. He has authored multiple peer-reviewed publications in internationally recognized journals, addressing donor gene polymorphisms, tumor recurrence prediction models, coagulation biomarkers, non-coding RNA regulatory networks, and immunosuppressive strategies. His work demonstrates a strong translational approach, bridging molecular research with clinical application to improve prognostic accuracy and therapeutic decision-making in liver transplantation and hepatobiliary surgery. In addition to his research contributions, Dr. Wang actively participates in funded scientific projects, contributing to studies on liver fibrosis, exosome-mediated regulation, and liver injury mechanisms. His combined clinical expertise, research productivity, and commitment to improving transplant outcomes position him as a dedicated and impactful physician-scientist in the field of hepatobiliary and transplant surgery.